Peregrine Pharmaceuticals, Inc. (PPHM) was a big mover last session, as its shares rose over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the healthcare company, as the stock is now up roughly 16% since Nov 7.
In the last 30-day time frame, the company did not see any estimate revision and the Zacks Consensus Estimate hasn’t been in a trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Peregrine currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
However, some better-ranked biotechnology stocks include Vanda Pharmaceuticals, Inc. (VNDA), Osiris Therapeutics, Inc. (OSIR) and InSite Vision Incorporated (INSV). All three stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment